FDA Approves 2 Denosumab Biosimilars for All Reference Medicine Indications – OncLive

In patients with multiple myeloma, the most common AEs observed in at least 10% of patients were diarrhea, nausea, anemia, back pain, thrombocytopenia …
Source: back pain